Daniel V. Santi
Founder at Prolynx LLC
Daniel V. Santi active positions
| Companies | Position | Start | End |
|---|---|---|---|
Prolynx LLC
 Prolynx LLC Miscellaneous Commercial ServicesCommercial Services Prolynx LLC engages in the development of proprietary drug delivery system for half-life extension of proteins, peptides, and small molecules. Its pipeline includes PLX038, PEG-PARP, IL-15, IL-2, PTH 1-34, GLP-1RA, and QMo IVT. The company was founded by Daniel V. Santi and Gary W. Ashley in 2010 and is headquartered in San Francisco, CA. | Director/Board Member | 2009-12-31 | - |
| Founder | 2009-12-31 | - | |
| President | 2009-12-31 | - |
Career history of Daniel V. Santi
Former positions of Daniel V. Santi
| Companies | Position | Start | End |
|---|---|---|---|
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Chairman | - | 2006-02-13 |
| Founder | - | 2006-02-13 | |
| President | - | 2006-02-13 | |
| The University of California, San Francisco | Corporate Officer/Principal | 1973-12-31 | 2000-12-31 |
Training of Daniel V. Santi
| The State University of New York | Doctorate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Founder | 2 |
| President | 2 |
| Doctorate Degree | 2 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Prolynx LLC
Prolynx LLC Miscellaneous Commercial ServicesCommercial Services Prolynx LLC engages in the development of proprietary drug delivery system for half-life extension of proteins, peptides, and small molecules. Its pipeline includes PLX038, PEG-PARP, IL-15, IL-2, PTH 1-34, GLP-1RA, and QMo IVT. The company was founded by Daniel V. Santi and Gary W. Ashley in 2010 and is headquartered in San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Daniel V. Santi
- Experience
